Instructions for Credit — This activity is accredited for 1.75 continuing education credits for nurse practitioners, nurses, and social workers. Participants must attend the free webinar in its entirety, submit the online evaluation form and complete and submit the online post-test with a passing score of 70% to earn credit. Once submitted, the certificate will be automatically generated as a PDF online.
Please retain a copy of the certificate for your records. For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc. at (609) 333-1693 or firstname.lastname@example.org.
You must be enrolled to complete this activity for credit, however, you are not required to enroll simply to view the presentation.
Target Audience — Nurse practitioners, nurses and oncology social workers involved in the care of patients with Non-Hodgkin Lymphoma.
Course Content Level for Social Workers — Intermediate and Advanced
|Learning Objectives — At the conclusion of this program, participants will be able to:|
|•||Describe the various types and subtypes of NHL|
|•||Identify tests used to diagnose disease and monitor treatment|
|•||Explain the overarching goals of treatment for the types of NHL|
|•||Explain approved and emerging treatment options, including CAR T-cell therapy, and the role of clinical trials|
|•||Describe strategies to manage treatment side effects as well as potential long-term and late effects of treatments|
|•||Describe the roles of the pharmacist, the nurse and the social worker in treating patients with NHL|
Provider — This activity is provided by The Leukemia & Lymphoma Society.
Continuing Education for Nurse Practitioners, Nurses, and Social Workers
Registered Nursing Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.75 continuing education contact hours through the California Board of Registered Nursing.
Social Worker Designation
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. LLS maintains responsibility for this course. ACE provider approval period: 12/10/17-12/14/2020. Social workers completing this course receive 1.75 continuing education credits.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for this program. Social workers will receive 1.75 CE clinical contact hours for this activity.
To view system requirements please go to https://llsce.org/system-requirements
For questions, grievances, or assistance with special needs (physical, etc.) please contact us at infocenter@LLS.org.
Disclosure of Conflicts of Interest — All faculty participating in continuing education activities by The Leukemia & Lymphoma Society are expected to disclose to activity participants any significant financial interest or other relationships with the manufacturer(s) of any commercial product(s) discussed in their presentations. The faculty are also expected to disclose any unlabeled or investigational uses of any product(s) discussed in their presentations.
Loretta J. Nastoupil, MD, Consultant: Bayer, Gilead, Novartis. Research Support: Celgene, Gilead.
Irene Lee, PharmD, BCOP, has nothing to disclose.
Emily Brigham, APRN, CNP, MSN, has nothing to disclose.
Disclaimer — Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
|Estimated time to complete activity: 1.75 hours|
|Date of initial release: June 22,2020|
|Valid for CE credit through: June 22, 2021|
Loretta J. Nastoupil, MD, completed her undergraduate degree at Texas Tech Health Sciences Center, graduating summa cum laude in 2003. She obtained her medical degree from the University of Texas Southwestern Medical School at Dallas in 2007. Dr. Nastoupil completed her internship and internal medicine residency at Washington University, Barnes-Jewish Hospital in St. Louis, Missouri. Following residency, she completed a hematology-medical oncology fellowship at Emory University, serving as Chief Fellow her last year.
Dr. Nastoupil joined the faculty at MD Anderson Cancer Center in 2013 as an Associate Professor in the Department of Lymphoma/ Myeloma. Dr. Nastoupil is a clinical researcher with a focus on lymphoma epidemiology and outcomes. The goal of her research is to identify high risk factors associated with lymphoma and eliminate disparities in outcomes to improve survival for all patients with lymphoma. She is actively involved in early phase drug development as well as immune therapy studies in lymphoma.
Irene Lee, PharmD, BCOP, received her doctorate of pharmacy degree from University of California, San Francisco, School of Pharmacy in 2016. She completed a general pharmacy practice residency and an oncology pharmacy residency at Medical University of South Carolina in 2018. She joined MD Anderson Cancer Center as a Clinical Pharmacy Specialist in 2018, focusing on providing pharmaceutical care to patients with lymphoma and myeloma.
Emily Brigham, APRN, CNP, MSN, received her undergraduate education at the University of Michigan and Hope College in Holland, Michigan where she completed her BSN. Emily began her nursing career working as an RN in 2007 in the Medical Intensive Care Unit at St. Mary’s Hospital – Mayo Clinic in Rochester, MN. She moved to Los Angeles to work at UCLA in the CV surgery, heart and lung transplant ICU. After one year in California, Emily returned to the Mayo Clinic where she returned as nurse practitioner in General Internal Medicine at Mayo Clinic in Rochester, MN. In June of 2018, she transferred to the Lymphoma Group within the Department of Hematology at Mayo Clinic. She has since achieved academic rank (Instructor of Medicine) and serves on multiple committees.
Resources for HCPs
Online & In-person free CME & CE courses: www.LLS.org/CE
Treating Blood Cancers podcasts: www.LLS.org/HCPpodcast
Clinical Trials and Research
- Clinical Trials: Learn more about clinical trials: LLS.org/ClinicalTrials
- Research: Focused on finding cures, driving research in areas of unmet medical need, and bridging the gap between academic discovery & drug development: LLS.org/Research
Advocacy dedicated to removing barriers to care: www.LLS.org/Advocacy
Resources for Patients
NHL Specific Resources – www.LLS.org/NHL
Free Information Booklets: www.LLS.org/Booklets
Telephone/Web Education Programs: www.LLS.org/Programs
Support Resources : www.LLS.org/Support
- Financial Assistance
- Travel Assistance
- Referral to Medication Access programs
- Information Resource Center
- LLS Chapters
- LLS Community (social media platform)
- Patti Robinson Kaufman First Connection Program (peer-to-peer)
- One-On-One Nutrition Consultations (PearlPoint)
Information Resource Specialists: www.LLS.org/IRC
Assist through treatment, financial & social challenges, and give accurate treatment and support information. HCPs can also order free materials to distribute to patients.
Clinical Trial Support Center: www.LLS.org/CTSC
Patients & caregivers work one-on-one with an LLS Clinical Trial Nurse Navigator who will help find clinical trials and personally assist throughout the clinical trial process, providing an additional resource to the HCP team.
- Phone: (800) 955-4572, M-F, 9 am to 9 pm ET
- Email: infocenter@LLS.org
Live chat: www.LLS.org/InformationSpecialists